ArticleBlood and lymphatic cancer : targets and therapy2026

Health Disparities in Acute Myeloid Leukemia Patients Undergoing Treatment with Tyrosine Kinase Inhibitor (TKI) Therapy Targeting FLT3, IDH1, or IDH2.

Manuel R Espinoza-Gutarra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.